CIRM Boosts its Score on the California Sunshine Index
Angel investors better informed on $12 billion investment in gene and cell therapy
The Golden State’s stem cell agency, which is investing $5 billion of taxpayer cash over the next decade, today scored 71 percent on the California Sunshine Index (CSI) for its upcoming board meeting next week.
With five calendar days left before its governing board meeting on March 24, the agency has posted supporting and backgrou…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.